Author | Mark D. Pegram, MD | OncLive

Author | Mark D. Pegram, MD

Articles

Dr. Pegram on the Development of Trastuzumab Biosimilars

April 29, 2019

Video

Mark D. Pegram, MD, Susy Yuan-Huey Hung Professor, co-director, Stanford's Molecular Therapeutics Program, director, Breast Cancer Oncology Program, Stanford Women's Cancer Center, discusses the development of trastuzumab biosimilars.

Dr. Pegram on Promising Novel Agents in HER2+ Metastatic Breast Cancer

March 22, 2019

Video

Mark D. Pegram, MD, Susy Yuan-Huey Hung Professor, co-director, Stanford’s Molecular Therapeutics Program, director, Breast Cancer Oncology Program, Stanford Women’s Cancer Center, discusses promising novel agents in the treatment of patients with HER2-positive metastatic breast cancer.

Dr. Pegram Discusses Challenges Once Biosimilars Hit US Market

January 19, 2019

Video

Mark D. Pegram, MD, Susy Yuan-Huey Hung Professor, co-director, Stanford’s Molecular Therapeutics Program, director, Breast Cancer Oncology Program, Stanford Women’s Cancer Center, discusses challenges biosimilars will face once they hit the United States market.

Dr. Pegram on the Manufacturing Process of Biosimilars

December 06, 2018

Video

Mark D. Pegram, MD, Susy Yuan-Huey Hung Professor, co-director, Stanford’s Molecular Therapeutics Program, director, Breast Cancer Oncology Program, Stanford Women’s Cancer Center, discusses the manufacturing process of biosimilars.

x